Naureen Hammed just started rotating in the Herranz Lab and will stay until the end of November. We hope you will like it here!
First R01 for the Herranz Lab!!
NIH/NCI funds our R01 grant entitled “The role of glutaminolysis as a therapeutic tatget in T-ALL“
So grateful for your support!
Dr. Herranz invited to present the lab’s research at the National Cancer Institute (NCI)
Thank you very much for the invitation, Dr. Vidigal! I had a fantastic time discussing science.
Summer Party 2019!
Amazing time at the Fette Sau, Wythe Hotel, William Vale Hotel and Brooklyn Bowl (together with the Ferrando Lab!)
Gabrielle’s Angel Foundation for Cancer Research (GAFCR) funds the Herranz Lab
GAFCR decided to fund our project investigating Sirt1 in T-ALL, thank you very much for your support for the next 3 years!!
Vicky da Silva-Diz obtains a postdoctoral fellowship from the New Jersey Commission on Cancer Research (NJCCR)
This 2-year fellowship will allow Vicky to dissect the role of glutaminolysis in T-ALL. Congrats Vicky!!
CLRA funds the Herranz Lab
The Children’s Leukemia Research Association (CLRA) decided to fund the Herranz Lab on our quest to investigate new therapeutic targets in T-ALL!! Thank you very much for your support!! We will work hard to make the most out of this project!
Xmas 2018 party!
We had a blast at Bowlero!
The Herranz Lab publishes a review paper in Trends in Cancer!
Check out our recently published review paper on the long-range transcriptional regulation of MYC in cancer!
Great job Olga!
https://www.cell.com/trends/cancer/fulltext/S2405-8033(18)30221-8
The Herranz Lab publishes in EMBO Reports!
Check out our recently published study in collaboration with Dr. Serrano and Dr. Fernandez-Marcos Labs in which we demonstrate that Sirt1 protects from KRas-induced NSCLCs!
http://embor.embopress.org/content/early/2018/07/18/embr.201643879
